Clinical Trial Update: Florbetapir Calibration to the Centiloid Scale [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates calibration of Florbetapir PET imaging to the Centiloid scale in Alzheimer's disease, with the trial completed and results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2017-03-09